[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@FWCWeather HereForTheFreeDonut

HereForTheFreeDonut posts on X about $vera, target, $veras, $XX the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

• X Week XXXXX -XX%
• X Month XXXXX +34%
• X Months XXXXX +752%
• X Year XXXXX +283%

Mentions: X #

• X Week XX -XX%
• X Month XX +27%
• X Months XX +3,200%
• X Year XX +278%

Followers: XXX #

• X Week XXX +2.30%
• X Month XXX +3.80%
• X Months XXX +5.50%
• X Year XXX +3.30%

CreatorRank: undefined #

Social Influence

Social category influence stocks XX% cryptocurrencies XXXX% technology brands XXXX% social networks XXXX%

Social topic influence $vera 25%, target 25%, $veras 8.33%, $99 8.33%, $uber 8.33%, ceo 8.33%, linkedin 8.33%, $snti XXXX%

Top accounts mentioned or mentioned by @seedy19tron @biotechiq @amaymd @adamfeuerstein @biotechnerd1 @andreagtc @biostocks @pharmdca @dough @grok @billackman @uber @dkhos @ubercom @semodough @rnaianalyst @ddz1928

Top assets mentioned Vera Therapeutics, Inc. Class A Common Stock (VERA) The XX% Community (99) Uber Technologies, Inc. (UBER)

Top Social Posts

Top posts by engagements in the last XX hours

"Amazing opportunity to buy $VERA. Otuska received the 1st FDA Approval for IGAN yesterday. $VERA has even better EGFR numbers and similar reduction in protein in urine. CANTOR: Reiterates $XXX PT HC Wainwright: $XX PT Wells Fargo: $XX PT @seedy19tron @BioStocks @Pharmdca"
X Link 2025-11-26T16:48Z XXX followers, XXX engagements

"BREAKING (part 1): $VERA's going to be a blockbuster From today's CITI Healthcare Conference: -KDIGO's next release of kidney disease guidelines is planned around expected approval of Atacicept in July '26. @_Biotech_iQ @A_May_MD @adamfeuerstein @seedy19tron @Biotechnerd1"
X Link 2025-12-03T21:36Z XXX followers, XXX engagements

"BREAKING (part 2): $VERA From today's CITI Healthcare Conference: --VERA identified XX additional autoimmune indications outside of kidney disease that Atacicept would have successful clinical outcomes. @_Biotech_iQ @A_May_MD @adamfeuerstein @seedy19tron @Biotechnerd1"
X Link 2025-12-03T21:38Z XXX followers, XXX engagements

"$VERA: JP Morgan: Price Target raised to $XX from $XX. 7:00 PM 12/3/25. Updated model following multiple competitive updates for sibeprenlimab. With market dynamics & TAM JPM sees the product as strategically attractive. @_Biotech_iQ @A_May_MD @adamfeuerstein @seedy19tron"
X Link 2025-12-04T00:17Z XXX followers, XXX engagements

"@BillAckman @Uber @dkhos Blast them with emails Executive Emails Dara Khosrowshahi (CEO): khosrowshahid@uber.com Troy Stevenson (Global Head of Customer Operations): stevensont@uber.com (or TroyS@uber.com on LinkedIn) Tomasz Krawczyk (Senior Director Community Operations): krawczykt@uber.com"
X Link 2025-12-06T15:43Z XXX followers, XXX engagements

"$SNTI: 12/9/25-Leerink Partners initiated coverage with a Outperform rating & a $XXXX price target. Positive Phase X clinical data for SENTI-202 presented at ASH showed a XX% ORR and XX% complete remission rate in relapsed/refractory acute myeloid leukemia. @A_May_MD @semodough"
X Link 2025-12-09T16:31Z XXX followers, XXX engagements

"@RNAiAnalyst 12/12: Wedbush raises price target on Wave Life Sciences adds to Best Ideas List Wedbush analyst Yun Zhong added Outperform-rated Wave Life Sciences to the firm's Best Ideas List and raised the price target on the stock to $XX from $20"
X Link 2025-12-12T11:58Z XXX followers, 2203 engagements